| 1 |
34159337 | Discovery of pan-ErbB inhibitors protecting from SARS-CoV-2 replication, inflammation, and lung injury by a drug repurposing screen. | 2021 Jun 15 |
1 |
| 2 |
30023006 | Frequency, impact and a preclinical study of novel ERBB gene family mutations in HER2-positive breast cancer. | 2018 |
1 |
| 3 |
25590338 | Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells. | 2015 |
8 |
| 4 |
24258993 | ERBB4 mutation analysis: emerging molecular target for melanoma treatment. | 2014 |
3 |
| 5 |
24628946 | Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma. | 2014 Jul |
1 |
| 6 |
25492965 | Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration. | 2014 Dec 9 |
1 |
| 7 |
22352796 | A water-based mechanism of specificity and resistance for lapatinib with ErbB family kinases. | 2012 Mar 27 |
1 |
| 8 |
19718025 | Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4. | 2009 Oct |
1 |